Danaher Corp. (DHR) to Release Earnings on Thursday
Danaher Corp. (NYSE:DHR) will be issuing its Q316 quarterly earnings data on Thursday, October 20th. Analysts expect the company to announce earnings of $0.82 per share and revenue of $4.14 billion for the quarter.
Danaher Corp. (NYSE:DHR) last issued its earnings results on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.22 by $0.03. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.76 billion. During the same period in the prior year, the business earned $1.08 EPS. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. On average, analysts expect Danaher Corp. to post $3.55 EPS for the current fiscal year and $3.9 EPS for the next fiscal year.
Danaher Corp. (NYSE:DHR) opened at 75.86 on Tuesday. The firm’s 50-day moving average is $78.00 and its 200 day moving average is $76.89. Danaher Corp. has a one year low of $61.60 and a one year high of $82.64. The company has a market capitalization of $52.38 billion, a PE ratio of 15.09 and a beta of 1.13.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a dividend of $0.125 per share. The ex-dividend date is Wednesday, September 28th. This represents a $0.50 annualized dividend and a dividend yield of 0.66%. Danaher Corp.’s dividend payout ratio is presently 9.94%.
In related news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the company’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $81.44, for a total value of $3,737,851.68. Following the completion of the transaction, the insider now directly owns 179,054 shares of the company’s stock, valued at $14,582,157.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Daniel L. Comas sold 96,446 shares of the company’s stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total value of $7,800,552.48. Following the completion of the transaction, the chief financial officer now directly owns 215,716 shares of the company’s stock, valued at $17,447,110.08. The disclosure for this sale can be found here. 12.60% of the stock is owned by corporate insiders.
A number of institutional investors have recently made changes to their positions in DHR. Wealthcare Capital Management LLC purchased a new stake in shares of Danaher Corp. during the second quarter worth $144,000. Mycio Wealth Partners LLC boosted its stake in shares of Danaher Corp. by 32.6% in the second quarter. Mycio Wealth Partners LLC now owns 1,612 shares of the company’s stock worth $163,000 after buying an additional 396 shares in the last quarter. Pinkerton Retirement Specialists LLC boosted its stake in shares of Danaher Corp. by 4,542.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,764 shares of the company’s stock worth $178,000 after buying an additional 1,726 shares in the last quarter. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Danaher Corp. during the second quarter worth $182,000. Finally, Bluestein R H & Co. purchased a new stake in shares of Danaher Corp. during the second quarter worth $202,000. 75.73% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have recently commented on DHR shares. Sanford C. Bernstein upgraded Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price target on the stock in a report on Thursday, June 23rd. Barclays PLC reiterated an “overweight” rating and set a $105.00 price target on shares of Danaher Corp. in a report on Monday, June 27th. Zacks Investment Research lowered Danaher Corp. from a “hold” rating to a “sell” rating in a report on Wednesday, June 29th. JPMorgan Chase & Co. reiterated a “buy” rating and set a $105.00 price target on shares of Danaher Corp. in a report on Thursday, June 30th. Finally, Goldman Sachs Group Inc. started coverage on Danaher Corp. in a report on Tuesday, July 5th. They set a “neutral” rating and a $74.00 price target on the stock. Eight investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $92.87.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.